跳至主要内容
临床试验/NCT04088279
NCT04088279Unknown不适用

Novel Quantitative Magnetic Resonance Imaging (MRI) Measures in the Assessment and Follow-up of Patients With Pulmonary Hypertension (PH)

Royal Brompton & Harefield NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年11月19日最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Fractions (% area of lung imaged)

研究概览

简要总结

A prospective study of the use of two novel MRI techniques (oxygen-enhanced and fourier decomposition MRI) in the initial diagnosis and follow-up of patients with Pulmonary Hypertension. The investigators believe these techniques may present a novel set of imaging biomarkers that may be used for risk stratification, prediction of treatment response and longitudinal disease monitoring. The reserach MRI is in addition to standard of care and will not affect treatment decisions.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of Pulmonary Hypertension.
  • Age 18 and over.

排除标准

  • Standard contra-indications to MRI (as per NHS MRI safety questionnaire).
  • Not medically fit for transfer to MRI.
  • Patient judged inappropriate for involvement in study by clinical team e.g. secondary to emotional burden of recent diagnosis.

结局指标

主要结局

Fractions (% area of lung imaged)

时间窗: Baseline and 3-6 months

Delta pO2 max (mmHg)

时间窗: Baseline and 3-6 months

Wash in and wash out time constants (min)

时间窗: Baseline and 3-6months

Signal Intensity Change (%)

时间窗: Baseline and 3-6months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验